CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. John M. Climaco$3.2M
Market Cap • 25/07/20242017
(há 7 anos)
2019
(5 years ago)
NASDAQ
Listagem
Houston
Sede • Texas5
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CNSPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.